Success Metrics

Clinical Success Rate
100.0%

Based on 48 completed trials

Completion Rate
100%(48/48)
Active Trials
6(8%)
Results Posted
4%(2 trials)

Phase Distribution

Ph phase_2
2
3%
Ph phase_3
10
13%
Ph phase_4
25
33%
Ph phase_1
2
3%
Ph early_phase_1
2
3%
Ph not_applicable
29
38%

Phase Distribution

4

Early Stage

2

Mid Stage

35

Late Stage

Phase Distribution70 total trials
Early Phase 1First-in-human
2(2.9%)
Phase 1Safety & dosage
2(2.9%)
Phase 2Efficacy & side effects
2(2.9%)
Phase 3Large-scale testing
10(14.3%)
Phase 4Post-market surveillance
25(35.7%)
N/ANon-phased studies
29(41.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

48 of 48 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

76

all time

Status Distribution
Active(9)
Completed(48)
Other(19)

Detailed Status

Completed48
unknown19
Recruiting5
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
76
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.9%)
Phase 12 (2.9%)
Phase 22 (2.9%)
Phase 310 (14.3%)
Phase 425 (35.7%)
N/A29 (41.4%)

Trials by Status

not_yet_recruiting23%
recruiting57%
unknown1925%
active_not_recruiting11%
enrolling_by_invitation11%
completed4863%

Recent Activity

Clinical Trials (76)

Showing 20 of 76 trialsScroll for more
NCT07401524Phase 4

Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage

Not Yet Recruiting
NCT07187544Not Applicable

Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery

Recruiting
NCT06333340Not Applicable

Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery

Recruiting
NCT07380529Not Applicable

Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients

Completed
NCT03899961Phase 4

Carbetocin Myocardium Trial 2014 Part 2

Completed
NCT06420297Phase 3

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Enrolling By Invitation
NCT06930391Not Applicable

Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

Recruiting
NCT06776926Not Applicable

Timing of Carbetocin Administration in Postpartum Hemorrhage

Completed
NCT06173531Phase 3

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Active Not Recruiting
NCT06946589Phase 4

Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

Not Yet Recruiting
NCT01262742Not Applicable

Carbetocin at Elective Cesarean Delivery

Completed
NCT06692621

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

Completed
NCT06285409Not Applicable

Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

Recruiting
NCT05924321Phase 1

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

Completed
NCT06159959

Carbetocin in the Prevention of Primary Postpartum Haemorrhage

Completed
NCT05986266Phase 1

Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss

Completed
NCT05664659Phase 4

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

Completed
NCT04182360Not Applicable

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.

Completed
NCT05110482Phase 4

Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section

Unknown
NCT03651882Phase 4

Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

Completed

Drug Details

Intervention Type
DRUG
Total Trials
76